Physics at the LHC: a short overview

The CERN Large Hadron Collider (LHC) started operation a few months ago. The machine will deliver proton-proton and nucleus-nucleus collisions at energies as high as sqrt(s)=14 TeV and luminosities up to L~10^{34} cm^{-2}s^{-1}, never reached before. The main open scientific questions that the seven LHC experiments -- ATLAS, CMS, ALICE, LHCb, TOTEM, LHCf and MOEDAL -- aim to solve in the coming years are succinctly reviewed.Comment: 9 pages, 16 plots. Invited review talk Hot-Quarks 2010, La Londe-Les-Maures, July 2010. J. Phys. Conf. Ser. 270, 012001 (2011). Minor typos correcte

Next to leading order spin-orbit effects in the motion of inspiralling compact binaries

Using effective field theory (EFT) techniques we calculate the next-to-leading order (NLO) spin-orbit contributions to the gravitational potential of inspiralling compact binaries. We use the covariant spin supplementarity condition (SSC), and explicitly prove the equivalence with previous results by Faye et al. in arXiv:gr-qc/0605139. We also show that the direct application of the Newton-Wigner SSC at the level of the action leads to the correct dynamics using a canonical (Dirac) algebra. This paper then completes the calculation of the necessary spin dynamics within the EFT formalism that will be used in a separate paper to compute the spin contributions to the energy flux and phase evolution to NLO.Comment: 25 pages, 4 figures, revtex4. v2: minor changes, refs. added. To appear in Class. Quant. Gra

Recent advances in electronic structure theory and their influence on the accuracy of ab initio potential energy surfaces

Recent advances in electronic structure theory and the availability of high speed vector processors have substantially increased the accuracy of ab initio potential energy surfaces. The recently developed atomic natural orbital approach for basis set contraction has reduced both the basis set incompleteness and superposition errors in molecular calculations. Furthermore, full CI calculations can often be used to calibrate a CASSCF/MRCI approach that quantitatively accounts for the valence correlation energy. These computational advances also provide a vehicle for systematically improving the calculations and for estimating the residual error in the calculations. Calculations on selected diatomic and triatomic systems will be used to illustrate the accuracy that currently can be achieved for molecular systems. In particular, the F+H2 yields HF+H potential energy hypersurface is used to illustrate the impact of these computational advances on the calculation of potential energy surfaces

Quark-Gluon Matter

A concise review of the experimental and phenomenological progress in high-energy heavy-ion physics over the past few years is presented. Emphasis is put on measurements at BNL-RHIC and CERN-SPS which provide information on fundamental properties of QCD matter at extreme values of temperature, density and low-x. The new opportunities accessible at the LHC, which may help clarify some of the current open issues, are also outlined.Comment: Minor changes to text. New refs. included. Updated figures with final dat

The Role of Toll-Like Receptor 2 in Inflammation and Fibrosis during Progressive Renal Injury

Tissue fibrosis and chronic inflammation are common causes of progressive organ damage, including progressive renal disease, leading to loss of physiological functions. Recently, it was shown that Toll-like receptor 2 (TLR2) is expressed in the kidney and activated by endogenous danger signals. The expression and function of TLR2 during renal fibrosis and chronic inflammation has however not yet been elucidated. Therefore, we studied TLR2 expression in human and murine progressive renal diseases and explored its role by inducing obstructive nephropathy in TLR2−/− or TLR2+/+ mice. We found that TLR2 is markedly upregulated on tubular and tubulointerstitial cells in patients with chronic renal injury. In mice with obstructive nephropathy, renal injury was associated with a marked upregulation and change in distribution of TLR2 and upregulation of murine TLR2 danger ligands Gp96, biglycan, and HMGB1. Notably, TLR2 enhanced inflammation as reflected by a significantly reduced influx of neutrophils and production of chemokines and TGF-β in kidneys of TLR2−/− mice compared with TLR2+/+ animals. Although, the obstructed kidneys of TLR2−/− mice had less interstitial myofibroblasts in the later phase of obstructive nephropathy, tubular injury and renal matrix accumulation was similar in both mouse strains. Together, these data demonstrate that TLR2 can initiate renal inflammation during progressive renal injury and that the absence of TLR2 does not affect the development of chronic renal injury and fibrosis

Systematic Review of Medicine-Related Problems in Adult Patients with Atrial Fibrillation on Direct Oral Anticoagulants

New oral anticoagulant agents continue to emerge on the market and their safety requires assessment to provide evidence of their suitability for clinical use. There-fore, we searched standard databases to summarize the English language literature on medicine-related problems (MRPs) of direct oral anticoagulants DOACs (dabigtran, rivaroxban, apixban, and edoxban) in the treatment of adults with atri-al fibrillation. Electronic databases including Medline, Embase, International Pharmaceutical Abstract (IPA), Scopus, CINAHL, the Web of Science and Cochrane were searched from 2008 through 2016 for original articles. Studies pub-lished in English reporting MRPs of DOACs in adult patients with AF were in-cluded. Seventeen studies were identified using standardized protocols, and two reviewers serially abstracted data from each article. Most articles were inconclusive on major safety end points including major bleeding. Data on major safety end points were combined with efficacy. Most studies inconsistently reported adverse drug reactions and not adverse events or medication error, and no definitions were consistent across studies. Some harmful drug effects were not assessed in studies and may have been overlooked. Little evidence is provided on MRPs of DOACs in patients with AF and, therefore, further studies are needed to establish the safety of DOACs in real-life clinical practice